Circulating miR-29a levels in patients with scleroderma spectrum disorder

Journal of Dermatological Science

Volumn 61, Issue 1, 2011, Pages 67-69

  Kawashita, Yoshio ^a   Jinnin, Masatoshi ^a   Makino, Takamitsu ^a   Kajihara, Ikko ^a   Makino, Katunari ^a   Honda, Noritoshi ^a   Masuguchi, Shinich ^a   Fukushima, Satoshi ^a   Inoue, Yuji ^a   Ihn, Hironobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Collagen; Dermatology; MicroRNA; Scleroderma; Systemic sclerosis

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA1; COLLAGEN TYPE 1 ALPHA2; MICRORNA; MICRORNA 29A; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; AGED; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RNA BINDING; SYSTEMIC SCLEROSIS; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; SCLERODERMA, DIFFUSE; SCLERODERMA, LIMITED;

EID: 78650677922     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.11.007     Document Type: Letter

References (10)

1. Korn J.H. Immunologic aspects of scleroderma. Curr Opin Rheumatol 1989, 1(4):479-484.
2. Mauch C., Krieg T. Fibroblast-matrix interactions and their role in the pathogenesis of fibrosis. Rheum Dis Clin North Am 1990, 16(1):93-107.
3. Jelaska A., Arakawa M., Broketa G., Korn J.H. Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts: increased proportion of high collagen-producing cells in systemic sclerosis fibroblasts. Arthritis Rheum 1996, 39(8):1338-1346.
4. LeRoy E.C. Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast. J Clin Invest 1974, 54(4):880-889.
5. Kroh E.M., Parkin R.K., Mitchell P.S., Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2010, 50(4):298-301.
6. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120(1):15-20.
7. Ihn H., Sato S., Fujimoto M., Kikuchi K., Igarashi A., Soma Y., et al. Measurement of anticardiolipin antibodies by ELISA using β2-glycoprotein I (β 2-GPI) in systemic sclerosis. Clin Exp Immunol 1996, 105(3):475-479.
8. Maricq H.R., McGregor A.R., Diat F., Smith E.A., Maxwell D.B., LeRoy E.C., et al. Major clinical diagnoses found among patients with Raynaud phenomenon from the general population. J Rheumatol 1990, 17(9):1171-1176.
9. Maricq H.R., Weinrich M.C., Keil J.E., Smith E.A., Harper F.E., Nussbaum A.I., et al. Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 1989, 32(8):998-1006.
10. Ihn H., Sato S., Tamaki T., Soma Y., Tsuchida T., Ishibashi Y., et al. Clinical evaluation of scleroderma spectrum disorders using a points system. Arch Dermatol Res 1992, 284(7):391-395.